Variations in Lung cancer risk among smokers

Journal of the National Cancer Institute

Volumn 95, Issue 6, 2003, Pages 470-478

  Bach, Peter B ^a   Kattan, Michael W ^a   Thornquist, Mark D ^b   Kris, Mark G ^a   Tate, Ramsey C ^a   Barnett, Matt J ^b   Hsieh, Lillian J ^a   Begg, Colin B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BETA CAROTENE; PLACEBO; RETINOL;

ACCURACY; ADULT; AGE; ARTICLE; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENDER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; METHODOLOGY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SMOKING CESSATION; SMOKING HABIT;

EID: 0037454225     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/95.6.470     Document Type: Article

References (49)

1. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
2. Black WC. Advances in radiology and the real versus apparent effects of early diagnosis. Eur J Radiol 1998;27:116-22.
3. Black WC. Overdiagnosis: an underrecognized cause of confusion and harm in cancer screening. J Natl Cancer Inst 2000;92:1280-2.
4. Patz EF Jr, Goodman PC, Bepler G. Screening for lung cancer. New Engl J Med 2000;343:1627-33.
5. Omenn GS, Goodman G, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Cancer Res 1994;54:2038s-43s.
6. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New Engl J Med 1996;334:1150-5.
7. Woloshin S, Schwartz LM, Welch HG. Risk charts: putting cancer in context. J Natl Cancer Inst 2002;94:799-804.
8. National Center for Health Statistics. U.S. decennial life tables for 1989-91. Vol. 1, No. 1. United States Life Tables. (PHS) 97-1150-1. Hyattsville (MD): Public Health Service. p. 44. [Accessed 2/4/2003.] Available at: http://www.cdc.gov/nchs/products/pubs/pubd/lftbls/decenn/1991-89.htm.
9. 9 Surgeon General Report: reducing the health consequences of smoking. [Accessed 1/31/2003.] Available at: http://www.cdc.gov/tobacco/sgr/sgr_1989/1989SGRChapter3pdf. p. 148.
10. Bepler G. Lung cancer epidemiology and genetics. J Thorac Imaging 1999;14:228-34.
11. The health consequences of smoking: cancer. A report of the Surgeon General. DHHS Publ No. 82-50179. Rockville (MD): U.S. Department of Health and Human Services; 1982.
12. Collett D. Modelling survival data in medical research. 1st ed. New York (NY): Chapman and Hall; 1994.
13. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
14. Efron B, Gong G. A leisurely look at the bootstrap, the jacknife, and cross-validation. Am Stat 1983;37:36-48.
15. Schumacher M, Hollander N, Sauerbrei W. Resampling and cross-validation techniques: a tool to reduce bias caused by model building? Stat Med 1997;16:2813-27.
16. Lorenz MO. Methods for measuring the concentration of wealth. Am Stat Assoc 1905;9:209-19.
17. Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508-13.
18. National Lung Screening Trial. National Cancer Institute. [Accessed: 1/6/2003.] Available at: http://cancer.gov/nlst.
19. Harrell FE. Regression modeling strategies: with applications to linear models, logisitic regression, and survival analysis. New York (NY): Springer, 2001.
20. Ries LA, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER cancer statistics review, 1973-1998. Bethesda (MD): National Cancer Institute; 2001. [Accessed 1/30/2003.] Available at: http://seer.cancer.gov/csr/1973_1998/.
21. Thun MJ, Calle EE, Rodriguez C, Wingo PA. Epidemiological research at the American Cancer Society. Cancer Epidemiol Biomarkers Prev 2000;9:861-8.
22. Lee TH, Brennan TA. Direct-to-consumer marketing of high-technology screening tests. New Engl J Med 2002;346:529-31.
23. Bach PB, Kelley MJ, Tate RC, McCrory DC. Screening for lung cancer: a review of the current literature. Chest 2003;123(1 Suppl):72S-82S.
24. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
25. Lung screening study ties up advisors, board sends it back to NCI for revision. Cancer Lett 2001;27:1-4.
26. Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol 1993;138:281-93.
27. Harris RE, Zang EA, Anderson JI, Wynder EL. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol 1993;22:592-9.
28. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 1996;88:183-92.
29. Perneger TV. Sex, smoking, and cancer: a reappraisal. J Natl Cancer Inst 2001;93:1600-2.
30. Kreuzer M, Boffetta P, Whitley E, Ahrens W, Gaborieau V, Heinrich J, et al. Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy. Br J Cancer 2000;82:227-33.
31. Osann KE, Anton-Culver H, Kurosaki T, Taylor T. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer 1993;54:44-8.
32. Prescott E, Osler M, Hein HO, Borch-Johnsen K, Lange P, Schnohr P, et al. Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology 1998;9:79-83.
33. Peto R. Influence of dose and duration of smoking on lung cancer rates. IARC Sci Publ 1986;(74):23-33.
34. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 1993;85:457-64.
35. Samet JM. The health benefits of smoking cessation. Med Clin North Am 1992;76:399-414.
36. Lubin JH, Blot WJ, Berrino F, Flamant R, Gillis CR, Kunze M, et al. Modifying risk of developing lung cancer by changing habits of cigarette smoking. Br Med J (Clin Res Ed) 1984;288:1953-6.
37. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857-62.
38. Fearon ER. The smoking gun and the damage done: genetic alterations in the lungs of smokers. J Natl Cancer Inst 1997;89:834-6.
39. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999;130:515-24.
40. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. New Engl J Med 1997;336:243-50.
41. Bach PB, Schrag D, Nierman DM, Horak D, White PJ, Young JW, et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001;98:3234-40.
42. Begg CB. The search for cancer risk factors: when can we stop looking? Am J Public Health 2001;91:360-4.
43. Zauber AG, Winawer SJ, Bond JH, Waye JD, Schapiro M, Stewart ET, et al. Can surveillance intervals be lengthened following colonoscopic polypectomy? Gastroenterology 1997;112:A50-50.
44. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
45. Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. New Engl J Med 2000;342:564-71.
46. Friedman GD, Tekawa I, Sadler M, Sidney S. Smoking and mortality: the Kaiser Permanente experience. Changes in cigarette-related disease risks and their implications for prevention and control. Smoking and Tobacco Control Monograph 8. Bethesda (MD): National Cancer Institute; 1997. p. 477-97.
47. Thun MJ, Day-Lally CA, Calle EE, Flanders WD, Heath CW Jr. Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health 1995;85:1223-30.
48. Enstrom JE, Heath CW. Smoking cessation and mortality trends among 118,000 Californians, 1960-1997. Epidemiology 1999;10:500-12.
49. Vineis P, Kogevinas M, Simonato L, Brennan P, Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res 2000;463:103-10.